Viscerotropic disease following yellow fever vaccination in Peru (Q40382408)

20 September 2017

Viscerotropic disease following yellow fever vaccination in Peru (English)

1 reference

20 September 2017

0 references

1 reference

1 reference

19

Thomas Monath

1 reference

20 September 2017

11

Erin Staples

1 reference

20 September 2017

16

Robert Lanciotti

1 reference

20 September 2017

17

Sherif Zaki

1 reference

20 September 2017

5

Steve Waterman

1 reference

20 September 2017

Alvaro Whittembury

1

1 reference

20 September 2017

Gladys Ramirez

2

1 reference

20 September 2017

Herminio Hernández

3

1 reference

20 September 2017

Alba Maria Ropero

4

1 reference

20 September 2017

María Ticona

6

1 reference

20 September 2017

Margo Brinton

7

1 reference

20 September 2017

Jorge Uchuya

8

1 reference

20 September 2017

Mark Gershman

9

1 reference

20 September 2017

Washington Toledo

10

1 reference

20 September 2017

Clarense Campos

12

1 reference

20 September 2017

Mario Martínez

13

1 reference

20 September 2017

Gwong-Jen J Chang

14

1 reference

20 September 2017

Cesar Cabezas

15

1 reference

20 September 2017

Joel M Montgomery

18

1 reference

20 September 2017

Edward Hayes

20

1 reference

20 September 2017

language of work or name

English

0 references

publication date

11 August 2009

1 reference

20 September 2017

1 reference

20 September 2017

27

1 reference

20 September 2017

43

1 reference

20 September 2017

5974-5981

1 reference

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Acute viscerotropic disease following vaccination against yellow fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Adverse event reports following yellow fever vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

History of thymoma and yellow fever vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Yellow fever-associated viscerotropic disease in Barcelona, Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Nucleic Acid Amplification Assays for Detection of La Crosse Virus RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Detection of Colorado Tick Fever viral RNA in acute human serum samples by a quantitative real-time RT-PCR assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Fatal hemorrhagic fever caused by West Nile virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Positional cloning of the murine flavivirus resistance gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Risk of fatal adverse events associated with 17DD yellow fever vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Rare case of fatal yellow fever vaccine-associated viscerotropic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Yellow fever vaccine-associated viscerotropic disease and death in Spain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.082

10.1016/J.VACCINE.2009.07.082

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference